Syntel, Inc. (SYNT) Tops Q3 EPS by 8c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Stifel sees AI supply constraints ahead of Q3 tech earnings
Weakness in Healthcare is Buying Opportunity for Syntel (SYNT) - Noble Financial
October 17, 2014 11:19 AM EDTNoble Financial maintains Syntel, Inc. (Nasdaq: SYNT) at Buy with a price target of $112 following Q3 results reported earlier this week.
Analyst Vincent Colicchio noted the following key points:
Reported third quarter 2014 EPS of $1.47, which exceeded our forecast and street consensus... More


